GlaxoSmithKline is going to finance a documentary about obesity. A good documentary on obesity is probably overdue and has the potential to be very interesting to me. An article in the New York Times has some more details about the movie and the controversy around Glaxo as a financial backer and the potential for this documentary to be a disguised infomercial for Alli, Glaxos over the counter weight loss drug. You may know alli from it's famous side-effects. Excreting dietary fat can get ugly.
The comparisons to An Inconvenient Truth from the NYT article are interesting since obese people serve an important role as a carbon sink.
Podcast
people visited the bayblab instead of doing their experiments
1 comments:
Best case scenario, I expect it will at least come out to be as ridiculously politically-skewed, one-sided and unscientific as "An Inconvenient Truth". Even before the GSK marketeers get their paws on it.
And maybe that's OK.
Post a Comment